Background and Purpose—Vascular prevention trials mostly count “yes/no” (binary) outcome events, eg, stroke/nostroke. Analysis of ordered categorical vascular events (eg, fatal stroke/nonfatal stroke/no stroke) is clinically relevantand could be more powerful statistically. Although this is not a novel idea in the statistical community, ordinal outcomeshave not been applied to stroke prevention trials in the past.Methods—Summary data on stroke, myocardial infarction, combined vascular events, and bleeding were obtained bytreatment group from published vascular prevention trials. Data were analyzed using 10 statistical approaches whichallow comparison of 2 ordinal or binary treatment groups. The results for each statistical test for each tri...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...
Background and Purpose—Vascular prevention trials mostly count “yes/no” (binary) outcome events, eg,...
BACKGROUND AND PURPOSE: Vascular prevention trials mostly count "yes/no" (binary) outcome events, eg...
Background: Vascular prevention trials typically use dichotomous event outcomes although this may be...
Background: Ordinalised vascular outcomes incorporating event severity are more informative than bin...
Most large acute stroke trials have shown no treatment effect. Functional outcome is routinely used ...
Background: Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
The online version of this article, along with updated information and services, is located on th
Background Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
Background and Purpose— Most large acute stroke trials have been neutral. Functional outcome is usua...
BackgroundEndpoints that are commonly used in trials of moderate/severe stroke may be less frequent ...
Background and purpose: Arguments persist as to whether parametric or nonparametric methods should b...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...
Background and Purpose—Vascular prevention trials mostly count “yes/no” (binary) outcome events, eg,...
BACKGROUND AND PURPOSE: Vascular prevention trials mostly count "yes/no" (binary) outcome events, eg...
Background: Vascular prevention trials typically use dichotomous event outcomes although this may be...
Background: Ordinalised vascular outcomes incorporating event severity are more informative than bin...
Most large acute stroke trials have shown no treatment effect. Functional outcome is routinely used ...
Background: Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
The online version of this article, along with updated information and services, is located on th
Background Many acute stroke trials have given neutral results. Sub-optimal statistical analyses ma...
Background and Purpose— Most large acute stroke trials have been neutral. Functional outcome is usua...
BackgroundEndpoints that are commonly used in trials of moderate/severe stroke may be less frequent ...
Background and purpose: Arguments persist as to whether parametric or nonparametric methods should b...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structur...
Background and Purpose-Many randomized clinical trials have evaluated the benefit of long-term use o...
Background and Purpose— There is a lack of agreement regarding measuring the effects of stroke treat...